Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Classifica tra le azioni #39281
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Prezzo delle azioni
$2.06
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$572.30K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-90.38%
Paese
CA
Scambia XORTX Therapeutics Inc. (XRTX)

Categoria

Storico del prezzo dell'azione per XORTX Therapeutics Inc. (XRTX)
Prezzo di chiusura più alto: $2.06 il 2026-08-01

Prezzo di chiusura più basso: $173.60 il 2015-10-01
Storico del prezzo dell'azione di XORTX Therapeutics Inc. dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$517.18 32.51%
US
$857.76 31.47%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$255.50 12.87%
BE